405520-68-5 Usage
Chemical Properties
White Crysstalline
Uses
Different sources of media describe the Uses of 405520-68-5 differently. You can refer to the following data:
1. 4-(Dimethylcarbamoyl)benzeneboronic acid used in coupling reactions and as intermediates.
2. Reactant for preparation of:? ;Selective glucocorticoid receptor agonists1? ;(thienopyridine)carboxamides as checkpoint 1 kinase (CHK1) inhibitors2? ;[(pyrrolo[2,3-b]pyridinyl)methylene]hydroxybenzofuranones as ATP-competitive inhibitors of the mammalian target of rapamycin3? ;Pyrrolopyridines as inhibitors of insulin-like growth factor-1 receptor tyrosine kinase4Reactant for:? ;Copper-mediated N-arylation of quinazolinediones5
General Description
May contain varying amounts of anhydride
Check Digit Verification of cas no
The CAS Registry Mumber 405520-68-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,0,5,5,2 and 0 respectively; the second part has 2 digits, 6 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 405520-68:
(8*4)+(7*0)+(6*5)+(5*5)+(4*2)+(3*0)+(2*6)+(1*8)=115
115 % 10 = 5
So 405520-68-5 is a valid CAS Registry Number.
InChI:InChI=1/C9H12BNO3/c1-11(2)9(12)7-3-5-8(6-4-7)10(13)14/h3-6,13-14H,1-2H3
405520-68-5Relevant articles and documents
DIARYLUREA DERIVATIVES AND THEIR USE AS CHLORIDE CHANNEL BLOCKERS
-
Page 35, (2008/06/13)
The present invention relates to novel diarylurea derivatives useful as chloride channel blockers. In other aspects the invention relates to the use of these compounds in a method for therapy, such as for the treatment of bone metabolic diseases, diseases responsive to modulation of the mast cell or basophil activity, diseases responsive to inhibition of angiogenesis, or sickle cell anaemia, and to pharmaceutical compositions comprising the compounds of the invention.
